Abstract
From the moment she entered the laboratory, Dr M. had the feeling that it would be a difficult day. Two persons were already waiting in front of her office. One of the visitors, the representative of the firm Cybcell which produced media for the culture of mammalian cells, was quickly sent to the researcher responsible for reagents’ orders, and then to the administrator who negotiated prices and delays. Dr M. was obliged, however, to receive immediately the second visitor, a scientist from the biotechnology firm where Dr M. was a consultant. The young man had come to discuss some urgent technical problems which had occurred during the production of highly purified antibodies crucial for the research conducted in the laboratory and destined for a medical test which was instrumental in making pronostics for brain tumors. The team working in the company could not replicate the specificity assessments completed in the laboratory. Dr M. and her visitor sat down to talk and try to decide who was right, but they were soon interrupted by a graduate student who stuck her head in to remind Dr M. that she had promised to attend the demonstration of a new machine for analysing DNA molecules and to discuss with the Automaton engineer possible ways of adapting their model to local needs. This was an important issue: the laboratory intended to buy several of these machines and open a DNA sequencing unit.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Notes
L. S. Reich, The Making of American Industrial Research, Science and Business at GE and Bell, 1876–1926 (Cambridge: Cambridge University Press, 1985).
D. A. Hounshell and J. Kenly Smith, Science and Corporate Strategy, DuPont R&D, 1902–1980 (Cambridge: Cambridge University Press, 1988).
W. B. Carlson, Innovation as a Social Process: Elihu Thomson and the rise of General Electric, 1870–1900 (Cambridge: Cambridge University Press, 1991).
R. Bud and S. Cozzens (eds), Invisible Connections (Bellingham, Wash, SPIE: 1992). N. Wise (ed.), The Values of Precision (Princeton: Princeton University Press, 1995).
T. Travis, The Rainbow Makers: The Origins of the Synthetic Dyestuff Industry in Western Europe. (Bethlehem, Pa.: Lenigh University Press, 1993).
N. Oudshoorn, Beyond the Natural Body: The Archaeology of Sex Hormones. London, Routledge: 1994
J. P. Swann, Academic Scientists and the Pharmaceutical Industry (Baltimore, Md.: Johns Hopkins University Press, 1988).
G. Bachelard, Le Matérialisme rationnel (Paris, Presses Universitaires de France: 1953).
S. Leigh Star, ‘Triangulating Clinical and Basic Research: British Localizationists, 1870–1906’, History of Science, vol. 24 (1986), pp. 29–48.
H. Marks, ‘Notes from the Underground: The Social Organization of Therapeutic Research’, in R. C. Maulitz and D. E. Long (eds), Great Rounds: One Hundred Years of Internal Medicine (Philadelphia: University of Pennsylvania Press, 1987)
T. Porter, Trust in Numbers: The Pursuit of Objectivity in Science and Public Life. (Princeton: Princeton University Press, 1995).
I. Löwy, ‘Nothing More To Be Done’, Science in Context, vol. 8 (1995) pp. 209–29.
K. Pavitt, ‘Academic Research, Technical Change, and Government Policy’, in J. Krige and D. Pestre (eds), Science in the 20th Century, Amsterdam: Harwood Academic Publishers, 1997).
Editor information
Editors and Affiliations
Copyright information
© 1998 Macmillan Press Ltd
About this chapter
Cite this chapter
Gaudillière, JP., Löwy, I. (1998). General Introduction. In: Gaudillière, JP., Löwy, I. (eds) The Invisible Industrialist. Science, Technology and Medicine in Modern History. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-26443-8_1
Download citation
DOI: https://doi.org/10.1007/978-1-349-26443-8_1
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-26445-2
Online ISBN: 978-1-349-26443-8
eBook Packages: Palgrave History CollectionHistory (R0)